182 related articles for article (PubMed ID: 26826119)
1. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit.
Maak M; Nitsche U; Keller L; Wolf P; Sarr M; Thiebaud M; Rosenberg R; Langer R; Kleeff J; Friess H; Johannes L; Janssen KP
Mol Cancer Ther; 2011 Oct; 10(10):1918-28. PubMed ID: 21788400
[TBL] [Abstract][Full Text] [Related]
3. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer.
Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA
Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109
[TBL] [Abstract][Full Text] [Related]
4. Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and Osteosarcoma.
Ehrenfeld M; Schrade A; Flisikowska T; Perl M; Hirsch ND; Sichler A; Geyer L; Flisikowski K; Wilhelm D; Schober SJ; Johannes L; Schnieke A; Janssen KP
Mol Cancer Ther; 2022 Apr; 21(4):686-699. PubMed ID: 35086950
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.
Stimmer L; Dehay S; Nemati F; Massonnet G; Richon S; Decaudin D; Klijanienko J; Johannes L
BMC Cancer; 2014 Dec; 14():916. PubMed ID: 25476116
[TBL] [Abstract][Full Text] [Related]
6. Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool.
Falguières T; Maak M; von Weyhern C; Sarr M; Sastre X; Poupon MF; Robine S; Johannes L; Janssen KP
Mol Cancer Ther; 2008 Aug; 7(8):2498-508. PubMed ID: 18687997
[TBL] [Abstract][Full Text] [Related]
7. A real-time cell-binding assay reveals dynamic features of STxB-Gb3 cointernalization and STxB-mediated cargo delivery into cancer cells.
Encarnação JC; Napolitano V; Opassi G; Danielson UH; Dubin G; Popowicz GM; Munier-Lehmann H; Buijs J; Andersson K; Björkelund H
FEBS Lett; 2020 Aug; 594(15):2406-2420. PubMed ID: 32473599
[TBL] [Abstract][Full Text] [Related]
8. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin and its use in targeted cancer therapy and imaging.
Engedal N; Skotland T; Torgersen ML; Sandvig K
Microb Biotechnol; 2011 Jan; 4(1):32-46. PubMed ID: 21255370
[TBL] [Abstract][Full Text] [Related]
11. Repurposing the Pentameric B-Subunit of Shiga Toxin for Gb3-Targeted Immunotherapy of Colorectal Cancer by Rhamnose Conjugation.
Liu Z; Li X; Lu Z; Qin X; Hong H; Zhou Z; Pieters RJ; Shi J; Wu Z
J Pharm Sci; 2022 Oct; 111(10):2719-2729. PubMed ID: 35905973
[TBL] [Abstract][Full Text] [Related]
12. Differential recognition of lipid domains by two Gb3-binding lectins.
Schubert T; Sych T; Madl J; Xu M; Omidvar R; Patalag LJ; Ries A; Kettelhoit K; Brandel A; Mely Y; Steinem C; Werz DB; Thuenauer R; Römer W
Sci Rep; 2020 Jun; 10(1):9752. PubMed ID: 32546842
[TBL] [Abstract][Full Text] [Related]
13. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy.
Luginbuehl V; Meier N; Kovar K; Rohrer J
Biotechnol Adv; 2018; 36(3):613-623. PubMed ID: 29432805
[TBL] [Abstract][Full Text] [Related]
14. Intracellular trafficking of Shiga-toxin-B-subunit-functionalized spherulites.
Bouter A; Delord B; Dransart E; Poirier C; Johannes L; van Effenterre D
Biol Cell; 2008 Dec; 100(12):717-25. PubMed ID: 18564063
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation.
Storck W; Meisen I; Gianmoena K; Pläger I; Kouzel IU; Bielaszewska M; Haier J; Mormann M; Humpf HU; Karch H; Müthing J
Biol Chem; 2012 Aug; 393(8):785-99. PubMed ID: 22944681
[TBL] [Abstract][Full Text] [Related]
16. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit.
Couture O; Dransart E; Dehay S; Nemati F; Decaudin D; Johannes L; Tanter M
Mol Imaging; 2011 Apr; 10(2):135-43. PubMed ID: 21439258
[TBL] [Abstract][Full Text] [Related]
17. Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1.
Tétaud C; Falguières T; Carlier K; Lécluse Y; Garibal J; Coulaud D; Busson P; Steffensen R; Clausen H; Johannes L; Wiels J
J Biol Chem; 2003 Nov; 278(46):45200-8. PubMed ID: 12944404
[TBL] [Abstract][Full Text] [Related]
18. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
19. Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
Maloney MD; Binnington-Boyd B; Lingwood CA
Glycoconj J; 1999 Dec; 16(12):821-8. PubMed ID: 11133022
[TBL] [Abstract][Full Text] [Related]
20. A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells.
Tomisch J; Busse V; Rosato F; Makshakova ON; Salavei P; Kittel AS; Gillon E; Lataster L; Imberty A; Meléndez AV; Römer W
Cells; 2023 Jul; 12(14):. PubMed ID: 37508560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
